Symphony Health

A significant alternative to IQVIA in the U.S. pharmaceutical data market, known for granular prescription and patient-level claims data serving mid-size to large pharma and biotech companies.

Symphony Health is a healthcare data and analytics company that provides comprehensive prescription and medical claims data, patient-level analytics, and market intelligence to pharmaceutical manufacturers, biotech firms, and life sciences organizations. The company aggregates and analyzes longitudinal patient data, prescriber behavior, and market dynamics to help clients make informed commercial decisions across drug launch planning, brand performance tracking, and competitive intelligence. Symphony Health operates one of the largest and most granular prescription data assets in the United States, covering retail, mail-order, and specialty pharmacy channels. The company was acquired by PRA Health Sciences, a global contract research organization, which expanded PRA's data and analytics capabilities beyond clinical research into the commercial life sciences space. This acquisition positioned Symphony Health's data assets alongside PRA's broader healthcare intelligence infrastructure, enabling integrated offerings that span clinical development through commercial execution. Symphony Health continues to operate under its established brand, serving clients who rely on its data for targeting, segmentation, and performance measurement. Within the healthcare data ecosystem, Symphony Health competes with major players such as IQVIA (formerly IMS Health/Quintiles) and Symphony Health differentiates itself through deep prescription-level data granularity, patient journey analytics, and flexible data delivery models. Its solutions are particularly valued by mid-size and specialty pharmaceutical companies seeking alternatives to larger data vendors, as well as by enterprise clients requiring highly customized analytics and data integration capabilities.